<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Polymerase chain reaction is commonly used to detect t(11;14)(q13;q32) and t(14;18)(q32;q21) chromosomal translocations associated with mantle cell <z:hpo ids='HP_0002665'>lymphoma</z:hpo> and follicular <z:hpo ids='HP_0002665'>lymphoma</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>We tested a total of 482 samples from patients with suspected non-Hodgkin's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> and sequenced unusual-sized t(11;14)(q13;q32) and t(14;18)(q32;q21) products from 33 of these patients </plain></SENT>
<SENT sid="2" pm="."><plain>BCL-1 or BCL-2 gene rearrangements were confirmed in 23 of 33 patients (70%) </plain></SENT>
<SENT sid="3" pm="."><plain>Considerable size variation was observed using t(11;14) primers, with MTCA and MTCB t(11;14) products ranging from 234 to 934 bp and 143 to 560 bp respectively </plain></SENT>
<SENT sid="4" pm="."><plain>Less variability was observed for t(14;18) Major Breakpoint Region (MBR) products (100-252 bp) but Minor Cluster Region (MCR) products ranged from 217 to 498 bp </plain></SENT>
<SENT sid="5" pm="."><plain>We demonstrate the utility of sequence analysis to confirm unusual-sized translocation products and reduce false-positive results because of nonspecific amplification </plain></SENT>
</text></document>